Best Compounded GLP-1 Providers (2026)

Cora names Hallandale Pharmacy and VialsRx as its US-licensed 503A partners, publishes a prominent FDA disclaimer stating compounded medications are not therapeutically equivalent to Ozempic, Wegovy, Mounjaro or Zepbound, and maintains a published cancellation and refund policy. On the criteria that matter for compounded medication, it leads the field.

• Named 503A pharmacy partners — rare in this market
• Explicit FDA non-equivalence disclaimer
• All-inclusive $99-$225/month with no membership fee
• Flat rate that does not increase with dose

Midi states its compounded medications come from licensed, 503B-accredited pharmacies. 503B outsourcing facilities are FDA-registered and must follow current good manufacturing practice requirements — a materially stronger quality position than 503A compounding, even though the product still is not FDA-approved.

• 503B-accredited pharmacy sourcing
• No membership fee; full dose-by-dose price table published
• Injectable and sublingual formulations available
• Clinician-led visits with insurance-covered options for qualifying patients

Names Rush Pharmacy (503A), prices flat across the whole 2mg-15mg progression, covers all 50 states, ships in 48 hours cold-chain, and offers genuinely penalty-free month-to-month cancellation. A complete package with nothing important hidden.

• Named 503A pharmacy partner: Rush Pharmacy
• Flat $179.99/month maintenance; full program $199 then $249.99
• All 50 states covered
• Pause or cancel anytime, no penalties

Nexlife is LegitScript-certified — an independent, continuously monitored certification that many GLP-1 telehealth operations do not hold — and publishes the specific quality-control assays its pharmacy runs: potency, sterility, pH and endotoxicity. It also states plainly that its products are not FDA-approved.

• LegitScript-certified telehealth platform
• Published third-party testing: potency, sterility, pH, endotoxicity
• Semaglutide from $165/month, tirzepatide from $215/month, as low as $155 on 12-month plans
• FSA and HSA accepted on all plans

Fifty 410 states its medication is compounded by independent FDA-registered 503A and 503B pharmacies, references specific pharmacy programs in its help centre, publishes the disclaimer that compounded medications are not FDA-approved finished drug products, and delivers the lowest effective per-month pricing we found.

• Tirzepatide from $133/month on a 3-month prepaid program
• States 503A and 503B FDA-registered pharmacy sourcing
• Free overnight or 2-day refrigerated shipping
• No payment until a provider approves you

Coby publishes the whole dose ladder rather than an entry price, states its FDA position clearly, names its state exclusions, and requires no subscription. You will know exactly what titration costs before you start.

• Full published ladder: $239 at 2.5mg to $439 at 12.5mg+
• Same-dose multi-month bundles from $179/month
• No subscription or membership required
• State exclusions published: AR, LA, MS, NM